ElizabethA.MullenMD
Pediatric Hematology & Oncology • Boston, MAAssistant Professor of Pediatrics, Dana-Farber Cancer Institute
Dr. Mullen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Boston, MA 02215Phone+1 617-632-1938Fax+1 617-632-4811
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1995 - 1998- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1992 - 1995
Yale School of MedicineClass of 1992
Certifications & Licensure
MA State Medical License 1995 - 2026
VT State Medical License 2023 - 2026
CT State Medical License 2022 - 2025
ME State Medical License 2022 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor Start of enrollment: 2006 Nov 06
- Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors Start of enrollment: 2012 Mar 01
- Biomarkers in Urine Samples From Patients With Wilms Tumor Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321.James I Geller, Lindsay A Renfro, Paul E Grundy, Elizabeth J Perlman, John A Kalapurakal
Pediatric Blood & Cancer. 2025-03-01 - Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies.Amy E Armstrong, Najat C Daw, Lindsay A Renfro, James I Geller, John A Kalapurakal
Cancer. 2025-01-15 - Outcomes of relapsed favorable-histology Wilms tumor in non-clinical trial setting.Netta Schneller, Najat Daw, Whitney Throckmorton, Elizabeth Mullen, Kylene DeSmith
Pediatric Blood & Cancer. 2025-01-01
Press Mentions
New NCCN Guidelines Analyze Evidence for Cancer Type Found Almost Exclusively in ChildrenFebruary 17th, 2021
More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 5th, 2021- Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children with Solid TumorsJuly 5th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
